In 2006, a survey of transmitted human immunodeficiency virus (HIV) drug resistance (TDR) was conducted in Lilongwe, Malawi. The survey followed the World Health Organization method to classify TDR to nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs) among primigravid women aged <25 years. Results of the 2006 survey showed <5% TDR in all drug classes. In 2009, TDR surveys using the same method were repeated in Lilongwe and expanded to Blantyre. Findings show that in Lilongwe TDR to NRTIs and PIs was <5%, whereas TDR to NNRTIs was 5%-15%. In Blantyre, TDR was <5% to all drug classes. Observed moderate TDR in Lilongwe is cause for concern and signals the...
<div><p>HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Sahara...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
The rapid scale-up of highly active antiretroviral therapy (HAART) and use of single dose Nevirapine...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26 448 ...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Following the World Health Organization (WHO)’s 3 by 5 initiative, antiretroviral treatment (ART) ...
Objective: To assess the emergence of transmitted HIV-1 drug resistance (TDR) in Kampala, Uganda, 10...
As more human immunodeficiency virus (HIV)–infected patients access combination antiretroviral thera...
As more human immunodeficiency virus (HIV)-infected patients access combination antiretroviral thera...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
Background: In a 2008-10 study, we found a pretreatment HIV drug resistance (PDR) prevalence of 18.2...
Im Jahr 2015 wurde Plasmaproben von 161 HIV-positive Menschen auf HIV-Drug-Resistance untersucht. Di...
BACKGROUND: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
<div><p>HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Sahara...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
The rapid scale-up of highly active antiretroviral therapy (HAART) and use of single dose Nevirapine...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Burkina Faso began rapid antiretroviral therapy (ART) scale-up in 2003 and by December 2009, 26 448 ...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
Following the World Health Organization (WHO)’s 3 by 5 initiative, antiretroviral treatment (ART) ...
Objective: To assess the emergence of transmitted HIV-1 drug resistance (TDR) in Kampala, Uganda, 10...
As more human immunodeficiency virus (HIV)–infected patients access combination antiretroviral thera...
As more human immunodeficiency virus (HIV)-infected patients access combination antiretroviral thera...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
Background: In a 2008-10 study, we found a pretreatment HIV drug resistance (PDR) prevalence of 18.2...
Im Jahr 2015 wurde Plasmaproben von 161 HIV-positive Menschen auf HIV-Drug-Resistance untersucht. Di...
BACKGROUND: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
<div><p>HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Sahara...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
The rapid scale-up of highly active antiretroviral therapy (HAART) and use of single dose Nevirapine...